Acasti Pharma Inc (ACST)
2.92
-0.01
(-0.29%)
USD |
NASDAQ |
Apr 26, 16:00
2.92
0.00 (0.00%)
After-Hours: 20:00
Acasti Pharma Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| February 29, 2016 | 0.0003M |
| November 30, 2015 | -0.0675M |
| August 31, 2015 | -0.0461M |
| May 31, 2015 | -0.0445M |
| February 28, 2015 | 0.0031M |
| November 30, 2014 | 0.2505M |
| August 31, 2014 | 0.2521M |
| Date | Value |
|---|---|
| May 31, 2014 | 0.4976M |
| February 28, 2014 | 0.4521M |
| November 30, 2013 | 0.3129M |
| August 31, 2013 | 0.7134M |
| May 31, 2013 | 0.6999M |
| February 28, 2013 | 0.707M |
| November 30, 2012 | 0.5776M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Revenue (TTM) Benchmarks
| Aurinia Pharmaceuticals Inc | 175.51M |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | 0.386M |
| Xenon Pharmaceuticals Inc | -- |
| ESSA Pharma Inc | -- |